21.59
+0.09
+(0.42%)
At close: April 15 at 4:00:00 PM EDT
22.01
+0.42
+(1.95%)
After hours: April 15 at 6:34:02 PM EDT
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
35.3
ESG Risk Score for Peers
Name | Total ESG Risk score | E | S | G |
---|---|---|---|---|
RNA Avidity Biosciences, Inc. | 35 | -- | -- | -- |
SANA Sana Biotechnology, Inc. | 35 | -- | -- | -- |
VERA Vera Therapeutics, Inc. | 35 | -- | -- | -- |
YMAB Y-mAbs Therapeutics, Inc. | 35 | -- | -- | -- |
VRDN Viridian Therapeutics, Inc. | 35 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 4/2025
VERA
Category Average
N/A None Controversy Level
None 4 Severe
-- VERA
0.5 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Products and Activities | Significant Involvement |
---|---|
Alcoholic Beverages | No |
Adult Entertainment | No |
Gambling | No |
Tobacco Products | No |
Animal Testing | Yes |
Fur and Specialty Leather | No |
Controversial Weapons | No |
Small Arms | No |
Catholic Values | No |
GMO | No |
Military Contracting | No |
Pesticides | No |
Thermal Coal | No |
Palm Oil | No |
Related Tickers
VRDN Viridian Therapeutics, Inc.
12.80
-3.76%
MLTX MoonLake Immunotherapeutics
36.77
+2.85%
SYRE Spyre Therapeutics, Inc.
12.71
-2.38%
PTGX Protagonist Therapeutics, Inc.
46.95
+4.26%
MRUS Merus N.V.
43.22
+1.86%
APGE Apogee Therapeutics, Inc.
32.85
-1.29%
TVTX Travere Therapeutics, Inc.
14.91
+0.54%
AKRO Akero Therapeutics, Inc.
38.08
+1.28%
KYMR Kymera Therapeutics, Inc.
25.46
+0.12%
IDYA IDEAYA Biosciences, Inc.
16.98
-0.76%